Building a unified model for drug synergy analysis powered by large language models

Drug synergy prediction is a challenging and important task in the treatment of complex diseases including cancer. In this manuscript, we present a unified Model, known as BAITSAO, for tasks related to drug synergy prediction with a unified pipeline to handle different datasets. We construct the training datasets for BAITSAO based on the context-enriched embeddings from Large Language Models for the initial representation of drugs and cell lines. After demonstrating the relevance of these embeddings, we pre-train BAITSAO with a large-scale drug synergy database under a multi-task learning framework with rigorous selections of tasks. We demonstrate the superiority of the model architecture and the pre-trained strategies of BAITSAO over other methods through comprehensive benchmark analysis. Moreover, we investigate the sensitivity of BAITSAO and illustrate its promising functions including drug discoveries, drug combinations-gene interaction, and multi-drug synergy predictions.

Authors

Institutions

Publication Details

Journal
Nature Communications
Published
2025-05-15
DOI
https://doi.org/10.1038/s41467-025-59822-y
Citations
3
Primary Topic
Computational Drug Discovery Methods
Type
article
Field-Weighted Citation Impact
4.51

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Building a unified model for drug synergy analysis powered by large language models

Tianyu Liu, Hongyu Zhao, Xiao Luo, Tinyi Chu
3 citations
Nature Communications
Computational Drug Discovery Methods
4.51
article

Building a unified model for drug synergy analysis powered by large language models

Tianyu Liu, Hongyu Zhao, Xiao Luo, Tinyi Chu
article en
3 citations

Abstract

Drug synergy prediction is a challenging and important task in the treatment of complex diseases including cancer. In this manuscript, we present a unified Model, known as BAITSAO, for tasks related to drug synergy prediction with a unified pipeline to handle different datasets. We construct the training datasets for BAITSAO based on the context-enriched embeddings from Large Language Models for the initial representation of drugs and cell lines. After demonstrating the relevance of these embeddings, we pre-train BAITSAO with a large-scale drug synergy database under a multi-task learning framework with rigorous selections of tasks. We demonstrate the superiority of the model architecture and the pre-trained strategies of BAITSAO over other methods through comprehensive benchmark analysis. Moreover, we investigate the sensitivity of BAITSAO and illustrate its promising functions including drug discoveries, drug combinations-gene interaction, and multi-drug synergy predictions.

Nature CommunicationsVol. 16(1)
University of California, Los Angeles (US), Yale University (US)
National Institutes of Health
Openalex Percentile: Top 6%
Computational Drug Discovery Methods
4.51
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Building a unified model for drug synergy analysis powered by large language models — Tianyu Liu, Hongyu Zhao, et al. · Nature Communications (2025) | TGRS Research Map | TGRS